StageAcq - Fin - II | Alive
About APS Healthcare
APS Healthcare is a provider of specialty healthcare solutions to more than 20 million members in the United States and Puerto Rico. The company partners with agencies in more than 20 states, representing more than 40 percent of the nation's Medicaid population. APS delivers customized, integrated healthcare solutions that help people engage in behaviors that optimize their health status. By uniting all participants in the healthcare landscape -- individuals, practitioners and payers -- APS improves overall health and reduces total healthcare expenditures.
Missing: APS Healthcare's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: APS Healthcare's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
APS Healthcare Patents
APS Healthcare has filed 2 patents.
Firearm components, Early revolvers, Architectural elements, Revolvers, Semi-automatic pistols
Firearm components, Early revolvers, Architectural elements, Revolvers, Semi-automatic pistols
Latest APS Healthcare News
Feb 28, 2017
(188.4 ) (1) 2016 amounts include earn-out revenues and litigation settlement, while 2015 amounts include initial loss on sale of APS Healthcare. Investment Portfolio As of December 31, 2016, Universal American had $356.0 million of cash and invested assets as follows: 50% is invested in U.S. Government and agency securities; The average credit quality of the investment portfolio is AA-; and Less than 1% of the investment portfolio is non-investment grade. A complete listing of our fixed income investment portfolio as of December 31, 2016 is available for review in the financial supplement located in the Investors – Financial Reports section of our website, www.UniversalAmerican.com . Balance Sheet and Liquidity As of December 31, 2016, Universal American’s Balance Sheet had the following characteristics: Unregulated cash and investments of $102.9 million; Total cash and investments were $356.0 million and total assets were $785.6 million, including $229.8 million in assets of discontinued operations; Total policyholder liabilities were $82.9 million and total liabilities were $516.2 million, including $237.8 million in liabilities of discontinued operations; Stockholders’ equity was $269.4 million and book value was $4.57 per diluted common share; Tangible book value per diluted common share (excluding accumulated other comprehensive income, goodwill and amortizing intangibles) was $3.39; $115 million of convertible senior notes with a carrying value of $96.5 million which bear cash interest of 4.0% per annum and an annual effective interest rate of 8.5%; and $40.0 million of mandatorily redeemable preferred stock, reported as a liability, with an annual dividend rate of 8.5%, which will mature in May 2017. As of December 31, 2016, the ratio of debt to total capital, excluding the effect of AOCI and including Universal American’s convertible senior notes and mandatorily redeemable preferred stock as debt, was 38.1%. Conference Call Given the pending transaction with WellCare, Universal American is not hosting a conference call in conjunction with this earnings release and does not expect to do so for future quarters. About Universal American Corp. Universal American (NYSE: UAM), through our family of healthcare companies, provides health benefits to people covered by Medicare. We are dedicated to working collaboratively with healthcare professionals, especially primary care physicians, in order to improve the health and well-being of those we serve and reduce healthcare costs. For more information on Universal American, please visit our website at www.UniversalAmerican.com . Forward Looking Statements This news release and oral statements made from time to time by our executive officers may contain "forward-looking" statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, known as the PSLRA. Such statements that are not historical facts are hereby identified as forward-looking statements and intended to be covered by the safe harbor provisions of the PSLRA and can be identified by the use of the words "believe," "expect," "predict," "project," "potential," "estimate," "anticipate," "should," "intend," "may," "will," and similar expressions or variations of such words, or by discussion of future financial results and events, strategy or risks and uncertainties, trends and conditions in our business and competitive strengths, all of which involve risks and uncertainties. Where, in any forward-looking statement, we or our management expresses an expectation or belief as to future results or actions, there can be no assurance that the statement of expectation or belief will result or be achieved or accomplished. Our actual results may differ materially from our expectations, plans or projections. We warn you that forward-looking statements are only predictions and estimates, which are inherently subject to risks, trends and uncertainties, many of which are beyond our ability to control or predict with accuracy and some of which we might not even anticipate. We give no assurance that we will achieve our expectations and we do not assume responsibility for the accuracy and completeness of the forward-looking statements. Future events and actual results, financial and otherwise, may differ materially from the results discussed in the forward-looking statements as a result of many factors, including the risk factors described in the risk factor section of our SEC reports. A summary of the information set forth in the "Risk Factors" section of our SEC reports and other risks includes, but is not limited to the following: the risk that the WellCare Transaction may not be completed in a timely manner or at all, which may adversely affect our business and the price of our common stock; the failure to satisfy the conditions to the consummation of the WellCare Transaction, including the receipt of certain governmental and regulatory approvals; the occurrence of any event, change or other circumstance that could give rise to the termination of the merger agreement with WellCare; the effect of the announcement or pendency of the WellCare Transaction on our business relationships, operating results, and business generally, including risks related to the WellCare Transaction disrupting current plans and operations and potential difficulties in employee retention as a result of the transaction; risks related to diverting management’s attention from our ongoing business operations; we are subject to extensive government regulation and frequent audit and the potential that CMS and/or other regulators could impose significant fines, penalties or operating restrictions on Universal American, including with respect to CMS audits, False Claims Act matters or Risk Adjustment Data Validation (“RADV”) audits; the Affordable Care Act, including efforts to repeal and replace the Affordable Care Act, could have a material adverse effect on our opportunities for growth and our financial results; we are investing significant capital and management attention in new and unproven business opportunities, including our Accountable Care Organizations (“ACOs”), where we take two-sided risk , that may not be profitable; the impact of the Centers for Medicare and Medicaid Services’ (“CMS”) Advance Notice regarding Medicare Advantage reimbursement rates for calendar year 2018 could have a material adverse effect on Universal American’s MA business; we may experience higher than expected medical loss ratios or lower revenues, especially with our new members in our Northeast markets, which could materially adversely affect our results of operations; If we are unable to develop and maintain satisfactory relationships with the providers of care to our members and ACO beneficiaries, our business and overall profitability could be materially adversely affected; if we fail to design and price our products properly and competitively or if the premiums and fees we charge are insufficient to cover the cost of health care services delivered to our members, our profitability may be materially adversely affected; our significant shareholders may have interests that are different than other shareholders and may sell or distribute their stock which could cause the price of our stock to decline; changes in governmental regulation or legislative reform could increase our costs of doing business and adversely affect our profitability; reductions in funding for Medicare programs could materially reduce our profitability; failure to reduce our operating and corporate costs could have a material adverse effect on our financial position, results of operations and cash flows; we may not be able to maintain or improve our CMS Star ratings which may cause certain of our plans to receive less bonuses or rebates than our competitors; changes in governmental regulation or legislative reform, including the impact of Sequestration, could reduce our revenues, increase our costs of doing business and adversely affect our profitability; a substantial portion of our revenues are tied to our Medicare businesses and regulated by CMS and if our government contracts are not renewed or are terminated, our business could be substantially impaired; any failure by us to manage our operations or to successfully complete or integrate acquisitions, dispositions and other significant transactions could harm our financial results, business and prospects; we could be subject to a cyber-attack or similar network breach that could damage our reputation and have a material adverse effect. Other unknown or unpredictable factors could also have material adverse effects on future results, performance or achievements of Universal American. All forward-looking statements included in this release are based upon information available to Universal American as of the date of the release, and we assume no obligation to update or revise any such forward-looking statements. (Tables to follow)
APS Healthcare Frequently Asked Questions (FAQ)
When was APS Healthcare founded?
APS Healthcare was founded in 1992.
Where is APS Healthcare's headquarters?
APS Healthcare's headquarters is located at 7125 Columbia Gateway Drive, Columbia.
What is APS Healthcare's latest funding round?
APS Healthcare's latest funding round is Acq - Fin - II.
How much did APS Healthcare raise?
APS Healthcare raised a total of $14.15M.
Who are the investors of APS Healthcare?
Investors of APS Healthcare include Consonance Capital, Kepro, Universal American Corp., GTCR and H.I.G. Ventures.
Who are APS Healthcare's competitors?
Competitors of APS Healthcare include United Surgical Partners International, VisiQuate, MedeAnalytics, SCIO Health Analytics, Avant Healthcare Professionals and 14 more.
Compare APS Healthcare to Competitors
United Emergency Services (UES) is a physician contract management company that focuses on providing experienced emergency department physicians and other health care providers to single hospital communities in the Southeastern United States.
Ardent Health Services, previously known as Behavioral Healthcare, invests in people, technology, facilities, and communities, producing high-quality care and extraordinary results. Ardent currently operates three health systems with a range of hospitals and employs multi-specialty physicians in multiple clinic locations across New Mexico, Oklahoma, and Texas. The company was founded in 1993 and is based in Nashville, Tennessee.
Mede is transforming healthcare by achieving advanced outcomes for its clients through a combination of performance intelligence solutions and deep healthcare expertise. Mede provides a full suite of customizable solutions for advanced financial, operational and clinical performance. These analytics solutions are delivered through Mede's Web-hosted analytics platform and are enhanced by healthcare-specific client teams to ensure speed to sustainable value.
Concierge Choice is a healthcare service company assisting physicians throughout the United States transitioning in their practices to Concierge Care. Patients joining a doctor's CCPprogram pay an annual membership fee to receive a screening physical performed by their physician that goes beyond the scope of most regular physicals. The revenue from this program aims to allow the doctor to gradually reduce his or her practice size and increase the time spent with participants in the program.
IMADENT Centro Radiologico Dentofacial es un laboratorio de analisis auxiliares en diagnostico de cirugia maxilofacial y especialidades odontologicas, oncologicas, otorrinolaringologia y cirugia reconstructiva. Nuestra estrecha colaboracion con ortodoncistas y nuestra tecnologia de vanguardia, nos han permitido mantenernos como una empresa lider en estudios para ortodoncia y servicios radiologicos especificos, dentales y de cabeza y cuello. A traves de esta pagina usted podra conocer mas acerca de nuestra empresa, obtener valiosa informacion, descargar formularios para recetas, programas para visualizar radiografias, imagenes o trazos, y solicitar una visita guiada a nuestras instalaciones. Le extendemos una cordial invitacion a conocer personalmente como seran atendidos sus pacientes, asi como nuestro equipo y sistema de trabajo
Aveta Inc. is a health organizations in the United States, caring for more than 220,000 Medicare beneficiaries and 320,000 commercial members. Aveta specializes in building provider networks and management service organizations that emphasize integration and coordination of healthcare. Aveta is headquartered in Ft. Lee, New Jersey and has operations in Puerto Rico, California and Illinois.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.